Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate
Status:
Withdrawn
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This pilot phase II trial studies docetaxel and prednisone in treating patients with newly
diagnosed stage I-II prostate cancer undergoing prostatectomy. Drugs used in chemotherapy,
such as docetaxel, work in different ways to stop the growth of tumor cells, either by
killing the cells or by stopping them from dividing. Biological therapies, such as
prednisone, may stimulate the immune system in different ways and stop cancer cells from
growing. Giving docetaxel and prednisone together may kill more tumor cells.